ADVITOS GmbH Revenue and Competitors
Estimated Revenue & Valuation
- ADVITOS GmbH's estimated annual revenue is currently $24.1M per year.
- ADVITOS GmbH's estimated revenue per employee is $251,000
Employee Data
- ADVITOS GmbH has 96 Employees.
- ADVITOS GmbH grew their employee count by 4% last year.
ADVITOS GmbH's People
Name | Title | Email/Phone |
---|
ADVITOS GmbH Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.6M | 78 | 11% | N/A | N/A |
#2 | $142.3M | 567 | -3% | N/A | N/A |
#3 | $8.5M | 34 | 0% | N/A | N/A |
#4 | $58.7M | 234 | 38% | N/A | N/A |
#5 | $15.1M | 60 | 11% | N/A | N/A |
#6 | $73.5M | 293 | 28% | N/A | N/A |
#7 | $28.4M | 113 | 14% | N/A | N/A |
#8 | $22.3M | 89 | 35% | N/A | N/A |
#9 | $96.4M | 384 | N/A | N/A | N/A |
#10 | $24.1M | 96 | 4% | N/A | N/A |
What Is ADVITOS GmbH?
ADVITOS developed the CE-marked and worldwide patented ADVOS technology (ADVanced Organ Support) ᅢᄁ¬ツᆲ¬タワ the only therapy worldwide offering multi organ support integrated in one single device. ADVOS improves survival of ICU patients by simultaneously supporting all three main detoxification organs: the liver, the lung and the kidney. The solution allows fluid-based elimination of: water-soluble toxins (kidney), protein-bound toxins (liver and kidney), and CO2 (lungs). In addition, ADVOS enables treatment of acid-base disbalances through patient individual correction of the blood pH value. The ADVOS therapy is used in intensive care units at 20 leading university hospitals throughout Germany and is on its way to penetrating the international market.
keywords:N/AN/A
Total Funding
96
Number of Employees
$24.1M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 147 | 35% | N/A |
#2 | $24.7M | 155 | 78% | N/A |
#3 | N/A | 349 | 5% | N/A |
#4 | $160.7M | 476 | 8% | N/A |